One of the most-used influenza medicines doesn’t work well in preventing severe complications that lead to hospitalization, according to a new study.
Dr. Emily McDonald and other Canadian researchers reviewed data from 15 randomized clinical trials, including eight that were conducted by the drugmaker Roche but not published. They analyzed whether the drug oseltamivir, known as Tamiflu, was associated with lower hospital admissions among outpatients infected with influenza.
